Bill
Private Health Insurance (Prostheses Application and Listing Fees) Amendment (Cost Recovery) Bill 2022
passed, as at 2023-03-16. Health and Aged Care portfolio.
- Sponsor
- Not recorded
- Portfolio
- Health and Aged Care
Recorded stages
- introduced — 2022-12-01
- second reading — 2022-12-01
- other — 2023-02-07
- second reading — 2023-02-07
- second reading — 2023-02-07
- other — 2023-02-07
- third reading — 2023-02-07
- introduced — 2023-02-08
- second reading — 2023-02-08
- second reading — 2023-03-07
- second reading — 2023-03-07
- committee — 2023-03-07
- third reading — 2023-03-07
- passed — 2023-03-07
- royal assent — 2023-03-16
Divisions
No divisions recorded. Most questions are decided on the voices; this does not establish that a bill was unopposed.
Plain-language summary
Written by a model from the explanatory memorandum; not the record, as at 2022-12-01.
This bill is part of a three-bill package that implements the 2021-22 Budget measure to modernise and improve the Prostheses List for private health insurance.
It would rename the Private Health Insurance (Prostheses Application and Listing Fees) Act and update its cost recovery arrangements, including imposing a levy on medical devices and human tissue products listed on the Prescribed List.
The levy amount would be specified in regulations, and the current application and listing fees would be removed.
- Renames the Private Health Insurance (Prostheses Application and Listing Fees) Act.
- Updates cost recovery arrangements under that Act.
- Imposes a levy on each medical device and human tissue product on the Prescribed List.
- Repeals existing application and listing fees.
- Authorises regulations and rules for levy-related matters.
- Renames the legislative instrument under the Act for consistency.
Sponsors of medical devices and human tissue products on the Prescribed List, and private health insurers.
Sources
em
billhome
frl act